<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>27(Suppl 2)</volume><submitter>Margaret T</submitter><journal>Annals of oncology : official journal of the European Society for Medical Oncology</journal><pagination>ii84-ii84</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4984075</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>P-288Global Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Compare Efficacy and Safety of PEGylated Recombinant Human Hyaluronidase (PEGPH20) Plus nab-Paclitaxel and Gemcitabine vs. Placebo Plus nab-Paclitaxel and Gemcitabine</pubmed_title><pmcid>PMC4984075</pmcid><pubmed_authors>Andrew H</pubmed_authors><pubmed_authors>Dimitrios C</pubmed_authors><pubmed_authors>Wilson W</pubmed_authors><pubmed_authors>Eric V</pubmed_authors><pubmed_authors>Tara S</pubmed_authors><pubmed_authors>Michel D</pubmed_authors><pubmed_authors>Andrea B</pubmed_authors><pubmed_authors>Margaret T</pubmed_authors><pubmed_authors>Lei Z</pubmed_authors><pubmed_authors>William H</pubmed_authors><pubmed_authors>Pippa C</pubmed_authors><pubmed_authors>Volker H</pubmed_authors><pubmed_authors>Sunil H</pubmed_authors><pubmed_authors>Michele R</pubmed_authors></additional><is_claimable>false</is_claimable><name>P-288Global Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Compare Efficacy and Safety of PEGylated Recombinant Human Hyaluronidase (PEGPH20) Plus nab-Paclitaxel and Gemcitabine vs. Placebo Plus nab-Paclitaxel and Gemcitabine</name><description/><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Jun</publication><modification>2025-04-26T20:35:17.076Z</modification><creation>2025-04-06T16:26:35.585Z</creation></dates><accession>S-EPMC4984075</accession><cross_references/></HashMap>